A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice
Clinical trial NCT07746583 · RECRUITING
Trial details
- NCT number
- NCT07746583
- Sponsor
- Janssen-Cilag Kft.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-08-07
- Primary completion
- 2029-01-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.